Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01763892 · ClinicalTrials.gov registry record
Physiologic Mechanisms in Pediatric Traumatic Brain Injury (TBI)
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 60
- Enrollment target
NCT01763892 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 60 participants.
The verdict
NCT01763892 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The aims of this study explore the relationships between cerebral vasospasm, apolipoprotein-E (apo-E) genotype, physiologic symptoms, and neurocognitive outcomes that may either intensify or ameliorate secondary injury, for children with a traumatic brain injury. Exploring the apo-E genotype will help us know if injury response is altered in certain children and will aid in developing interventional approaches.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-12 |
| Est. Completion | 2015-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01763892
The ClinicalTrials.gov registry entry for NCT01763892 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01763892 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01763892 about?
NCT01763892 is a clinical study titled "Physiologic Mechanisms in Pediatric Traumatic Brain Injury (TBI)". The aims of this study explore the relationships between cerebral vasospasm, apolipoprotein-E (apo-E) genotype, physiologic symptoms, and neurocognitive outcomes that may either intensify or ameliorate secondary injury, for children with a traumatic brain injury. Exploring the apo-E genotype will he...
What is the current status of trial NCT01763892?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2012-12. Estimated completion is 2015-09.
Who is sponsoring clinical trial NCT01763892?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.